News voyager therapeutics
Witryna28 mar 2024 · CAMBRIDGE, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking … Witryna1 dzień temu · What happened. Shares of CRISPR Therapeutics ( CRSP 16.66%) were up 15% Thursday morning, a day after a drug-pricing group said the company's single …
News voyager therapeutics
Did you know?
Witryna13 godz. temu · Communiqué de presse: Nicox : Redevances supplémentaires attendues à partir de 2024 suite au dépôt d'une demande d’autorisation de mise sur le marché de ZERVIATE en Chine Witryna9 sie 2024 · Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER TM AAV Capsid and Vectorized Antibody Platform Technologies. Proprietary AAV capsids to power second-generation efforts in Huntington’s disease and ALS, pre-clinical programs in spinal muscular atrophy and …
Witryna28 mar 2024 · CAMBRIDGE, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today presented new data from its anti-tau antibody program for Alzheimer’s disease (AD) and from its GBA1 gene therapy … WitrynaVoyager Therapeutics, Inc. Daily – Vickers Top Buyers & Sellers for 02/02/2024 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the …
Witryna2 godz. temu · LEUVEN, Belgium and STRASBOURG, France and PHILADELPHIA, April 14, 2024 /PRNewswire/ -- Flamingo Therapeutics ("Flamingo") today … Witryna4 paź 2024 · CAMBRIDGE, Mass. October 4, 2024 -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy and neuroscience company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, today announced that Pfizer, Inc. (NYSE: PFE) has exercised its option to license a novel capsid …
WitrynaIn the News. Voyager Therapeutics Presents New Data Supporting Tau Antibody Program for Alzheimer’s Disease and GBA1 Gene Therapy Program for Parkinson’s …
Witryna12 mar 2024 · Voyager Therapeutics' significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public … room h2o bathroomsWitryna1 dzień temu · Alentis décroche sa série C (13/04/2024) La biotech franco-suisse développant des traitements contre la fibrose et la cancer en ciblant la protéine Claudin-1 poursuit sa trajectoire avec un tour de série C de 96 M€ sursouscrit, emmené par Jeito Ventures avec deux nouveaux entrants aux côtés d’actionnaires existants. Lire la suite. room hair 北千住Witryna10 mar 2024 · News for Voyager Therapeutics Inc. Benzinga 14d. Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2024. TipRanks 15d. Voyager … room grace hotel new yorkWitryna22 mar 2024 · Most relevant news about VOYAGER THERAPEUTICS, INC. 03/17: Insider Sell: Voyager Therapeutics: MT. 03/10: Oppenheimer Initiates Coverage on … room hairdresserWitryna4 paź 2024 · CAMBRIDGE, Mass. October 4, 2024 -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a gene therapy and neuroscience company developing life … room harmonizerWitrynaCAMBRIDGE, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today presented new data from its anti-tau antibody program for Alzheimer’s disease (AD) and from its GBA1 gene therapy program for … room hampers for indian weddingWitryna6 mar 2024 · CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking … room hanging decor